Status:
COMPLETED
Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.
Lead Sponsor:
Carevive Systems, Inc.
Conditions:
Lung Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This Study is a case control Study conducted with 100 patients with a solid tumor cancer diagnosis (lung, breast, or gynecologic cancer). Records of 50 patients who received treatment plans as standar...
Eligibility Criteria
Inclusion
- All participants must be 18 years of age or older.
- Subject participants must have a diagnosis of a breast, lung, or gynecologic cancer.
- Patients must have completed their navigation visit and received a Treatment Care Plan.
- Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- Subjects must be starting or receiving treatment.
- All participants must be able to understand English.
Exclusion
- Any patient who cannot understand written or spoken English.
- Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
Key Trial Info
Start Date :
February 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04772118
Start Date
February 16 2021
End Date
November 1 2021
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mitchell Cancer Institute
Mobile, Alabama, United States, 36604